Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV | |
Cheng, Yong1,2,3; Schorey, Jeffrey S.1,2,3; Zhang, Cheng-Cai5; Tan, Xuejuan1,4 | |
Corresponding Author | Cheng, Yong(ycheng5@nd.edu) |
2017 | |
Source Publication | CURRENT PHARMACEUTICAL DESIGN
![]() |
ISSN | 1381-6128 |
Volume | 23Issue:29Pages:4369-4389 |
Abstract | Infectious diseases that are caused by pathogenic microbes such as bacteria, viruses, parasites or fungi remain the top major cause of death across the world, particularly in low income countries, and may be transmitted from person to person, or from insects or animals. In general, infectious diseases may be treated with antimicrobial agents including antibiotics, antiviral, antifungal or antiparasitic medications. The therapeutic application of antimicrobial drugs in the 20th century substantially contributed to the global control of infectious diseases worldwide. However, pathogenic microbes have evolved various mechanisms to render the antimicrobial drugs less effective. This has resulted in an increasing number of people infected with pathogenic microbes that are resistant to antimicrobial drugs, and in some cases leading to untreatable infections. Therefore, new antimicrobial drugs are urgently needed to prevent possible recurrence and emergence of previously treatable infectious diseases. In the past decades, protein kinase inhibitors have become an attractive area in the development of novel antimicrobial drugs. In the current review, we will describe the recent efforts in the development of microbial and host protein kinase-targeting inhibitors as potential antimicrobial drugs against HIV, tuberculosis and malaria. |
Keyword | Protein kinase inhibitors antimicrobial drugs infectious diseases tuberculosis malaria AIDS |
DOI | 10.2174/1381612823666170612122429 |
Indexed By | SCI ; SCI |
Language | 英语 |
WOS Research Area | Pharmacology & Pharmacy |
WOS Subject | Pharmacology & Pharmacy |
WOS ID | WOS:000415378600013 |
WOS Keyword | PARASITE PLASMODIUM-FALCIPARUM ; CYCLIN-DEPENDENT KINASES ; BRUTONS TYROSINE KINASE ; YEAST SCHIZOSACCHAROMYCES-POMBE ; 2-COMPONENT REGULATORY SYSTEM ; GLYCOGEN-SYNTHASE KINASE-3 ; SIGNAL-TRANSDUCTION SYSTEM ; HOST-DIRECTED THERAPIES ; CELL-DIVISION CYCLE ; DOUBLE-STRANDED-RNA |
Publisher | BENTHAM SCIENCE PUBL LTD |
Citation statistics | |
Document Type | 期刊论文 |
Identifier | http://ir.ihb.ac.cn/handle/342005/30742 |
Collection | 藻类生物学及应用研究中心_期刊论文 |
Corresponding Author | Cheng, Yong |
Affiliation | 1.Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA 2.Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA 3.Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA 4.Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA 5.Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei, Peoples R China |
Recommended Citation GB/T 7714 | Cheng, Yong,Schorey, Jeffrey S.,Zhang, Cheng-Cai,et al. Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV[J]. CURRENT PHARMACEUTICAL DESIGN,2017,23(29):4369-4389. |
APA | Cheng, Yong,Schorey, Jeffrey S.,Zhang, Cheng-Cai,&Tan, Xuejuan.(2017).Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV.CURRENT PHARMACEUTICAL DESIGN,23(29),4369-4389. |
MLA | Cheng, Yong,et al."Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV".CURRENT PHARMACEUTICAL DESIGN 23.29(2017):4369-4389. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment